MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$335M
1-Year Return
7.01%
This Quarter Return
+25.51%
1 Year Return
+7.01%
3 Year Return
+65.15%
5 Year Return
+135.64%
10 Year Return
+335.37%
AUM
$5.64B
AUM Growth
+$763M
(+16%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
23.75%
Holding
2,653
New
149
Increased
768
Reduced
1,024
Closed
109
Top Buys
| 1 |
Amazon
AMZN
|
+$7.07M |
| 2 |
AbbVie
ABBV
|
+$5.59M |
| 3 |
DexCom
DXCM
|
+$4.85M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$4.4M |
| 5 |
Microsoft
MSFT
|
+$4.21M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$56.4M |
| 2 |
Cisco
CSCO
|
+$11M |
| 3 |
AGN
Allergan plc
AGN
|
+$8.8M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$8.05M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$7.62M |
Sector Composition
| 1 | Technology | 23.84% |
| 2 | Healthcare | 14.19% |
| 3 | Financials | 11.88% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
NCR Voyix
VYX
$1.77B
| $429K | 0.01% |
40,364
-24,536
| -38% | -$261K |
|
|
RVNC
1327
DELISTED
Revance Therapeutics, Inc.
RVNC
| $429K | 0.01% |
17,562
+1,976
| +13% | +$48.3K |
|
1328
HEICO Class A
HEI.A
$34.9B
| $429K | 0.01% |
5,277
-127
| -2% | -$10.3K |
|
1329
Cimpress
CMPR
$1.4B
| $428K | 0.01% |
5,605
| – | – |
|
|
GTY
1330
Getty Realty Corp
GTY
$1.6B
| $428K | 0.01% |
14,409
+1,401
| +11% | +$41.6K |
|
1331
MaxLinear
MXL
$1.37B
| $427K | 0.01% |
19,905
| – | – |
|
|
PTLA
1332
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $426K | 0.01% |
23,656
| – | – |
|
|
ARNC
1333
DELISTED
Arconic Corporation
ARNC
| $425K | 0.01% |
+30,529
| New | +$425K |
|
1334
Dropbox
DBX
$8.34B
| $424K | 0.01% |
19,498
+4,667
| +31% | +$102K |
|
1335
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $424K | 0.01% |
17,400
| – | – |
|
1336
Yum China
YUMC
$16.1B
| $424K | 0.01% |
8,812
-13,381
| -60% | -$643K |
|
1337
Apollo Global Management
APO
$79B
| $423K | 0.01% |
+8,471
| New | +$423K |
|
1338
Addus HomeCare
ADUS
$2.03B
| $423K | 0.01% |
4,567
+477
| +12% | +$44.2K |
|
|
ITCI
1339
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $422K | 0.01% |
16,452
| – | – |
|
1340
Tandem Diabetes Care
TNDM
$829M
| $422K | 0.01% |
4,269
-12,691
| -75% | -$1.26M |
|
1341
Light & Wonder
LNW
$7.48B
| $422K | 0.01% |
27,277
-3,584
| -12% | -$55.4K |
|
1342
Schrodinger
SDGR
$1.37B
| $422K | 0.01% |
4,605
| – | – |
|
1343
Acadia Pharmaceuticals
ACAD
$3.98B
| $421K | 0.01% |
8,688
-25,006
| -74% | -$1.21M |
|
1344
Twist Bioscience
TWST
$1.53B
| $421K | 0.01% |
9,284
+1,696
| +22% | +$76.8K |
|
1345
AutoNation
AN
$8.37B
| $420K | 0.01% |
11,184
-4,373
| -28% | -$164K |
|
|
VGR
1346
DELISTED
Vector Group Ltd.
VGR
| $419K | 0.01% |
58,715
+11,143
| +23% | +$79.5K |
|
1347
Opko Health
OPK
$1.11B
| $416K | 0.01% |
122,006
-48
| -0% | -$164 |
|
1348
SS&C Technologies
SSNC
$21.8B
| $415K | 0.01% |
7,351
-7,196
| -49% | -$406K |
|
1349
Knowles
KN
$1.9B
| $415K | 0.01% |
27,202
+2,257
| +9% | +$34.4K |
|
1350
Gray Television
GTN
$598M
| $415K | 0.01% |
29,749
| – | – |
|